Keyphrases
Glycoprotein
100%
Imatinib
100%
Binding Mode
100%
Tyrosine Kinase Inhibitor
20%
High Affinity
20%
Genetic Variants
20%
Chronic Myeloid Leukemia
20%
Gastrointestinal Stromal Tumor
20%
Low Affinity
20%
Kinase Target
20%
Binding Studies
20%
X-ray Structure
20%
Plasma Protein Binding
20%
Extended Conformation
20%
Quinone Reductase
20%
Spectral Changes
20%
Molecular Modeling Calculation
20%
High-affinity Interaction
20%
Biochemistry, Genetics and Molecular Biology
Imatinib
100%
Glycoprotein
100%
Conformation
40%
X Ray
20%
Genetic Divergence
20%
Tyrosine Kinase Inhibitor
20%
Reductase
20%
Molecular Modeling
20%
Binding Study
20%
Myeloid
20%
Molecular Model
20%
Plasma Protein Binding
20%
Oxidoreductase
20%
Phosphotransferase
20%
Kinase
20%